Weight-loss drug may leave stomach full despite fasting, study warns

NCT ID NCT07398222

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether people taking tirzepatide (a drug for obesity and diabetes) still have food or liquid in their stomach after the recommended fasting period. Using a simple ultrasound, researchers will compare 30 adults who take tirzepatide with those who don't. The goal is to understand if this medication increases the risk of stomach contents entering the lungs during anesthesia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FULL STOMACH STATUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Israelita Albert Einstein

    RECRUITING

    São Paulo, São Paulo, 05652900, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.